IPF and Ossification: Who Knew?

Kevin Olson avatar

by Kevin Olson |

Share this article:

Share article via email
awareness, Fight for Air Climb, ossification, diagnosis

After my idiopathic pulmonary fibrosis (IPF) diagnosis, I was in denial about having the disease. So, I had a video-assisted thoracoscopic lung biopsy in July 2014.

The pathologist said my diagnosis was “fibrosing and interstitial pneumonia with foci of organizing pneumonia with both hyalinization and extensive, somewhat dendriform ossification.”

Yes, reread that. It said bone/calcium deposits were in my lungs — another sharp turn and dive on the roller coaster.

2014 biopsy findings

The pathologist sent the biopsy slides to the Mayo Clinic for confirmation. Following are some comments from Mayo’s biopsy summary:

  • “Thank you very much for the opportunity to review this challenging case.” This comment did not give me a warm feeling about the biopsy.
  • “The sections show an unusual combination of findings.” This was an indication that my IPF was unique to me.
  • “Finally, given the unusual nature of the case, I’d like to keep these slides for our teaching files.” Self-explanatory.

Additionally, the report mentioned stellate and linear opacities in my lungs that were unchanged since 2012. This information was an indirect indication that I had IPF in 2012 but was not diagnosed at the time. 

The summary went into a discussion about usual interstitial pneumonia with dendriform ossification. It also discussed the possibility of dendriform ossification by itself. The consensus was that I had usual interstitial pneumonia with dendriform ossification.

Second opinion

After my biopsy, my pulmonologist referred me to an interstitial lung disease (ILD) pulmonologist. The ILD pulmonologist said he had at most three IPF patients with ossification out of 500 patients. He mentioned that my scarring was in the lower lung lobes, which is nontypical. Also, he barely heard any crackles. 

As I learned about IPF and biopsies, I discovered that the primary method of IPF diagnosis is a high-resolution computed tomography scan. A biopsy was secondary. My thoughts were that I made a mistake having the biopsy. My ILD pulmonologist confirmed I needed the biopsy.

I emailed a former classmate at the U.S. Military Academy at West Point and told him about my ossification. He found that there have been 100 ossification cases since about 1880. When researching for ossification, I found the instances in autopsies. The bad news just kept coming.

Dendriform pulmonary ossification is another rare disease that is most likely diagnosed by surgery or autopsies. There are 1.63 cases per 1,000 autopsies.

Approximately 200,000 people in the U.S. have PF. If you multiple 200,000 by 1.63, and divide by 1,000, you get 326 people who might have IPF with dendriform ossification. This was another indication that I was different from most other people with IPF.

Having ossification excluded me from clinical trials because of my atypical IPF scarring. Research companies didn’t want a stand-alone variant IPF case. Over time, the criteria changed and allowed me to be in a trial, but by that time, I had IPF for too long, which disqualified me for studies. You win some and lose some.

2017 biopsy review

In 2017, a pathologist at the Barnes-Jewish Hospital Lung Transplant Center reviewed my biopsy slides. Some conclusions were:

  • The findings mentioned the appearance of extensive bone within the lung. Additionally, the bone appeared to be present within essentially normal lungs.
  • “There is little or no honeycombing fibrosis present, which would be very unusual in UIP [usual interstitial pneumonia], where honeycombing is typically the dominant feature that is seen.”
  • “The biopsy does not demonstrate the uniform and diffuse fibrosis that one would expect to see in typical cases of nonspecific interstitial pneumonitis (NSIP).”
  • “Represents patchy nonspecific fibrosis associated with dendriform ossification of the lung, as perhaps a stand-alone variant of IPF.”

My conclusion was that I had a slow-progressing ILD. It started at least in the early 2000s. The biopsy was inconclusive about which disease was primary or secondary. Was IPF primary and ossification secondary, or vice versa? Knowing my health history, I believed the ossification was primary, then the IPF developed.

An August 2020 surgery pathology report from Barnes-Jewish Hospital confirmed everything I stated above. It added that secondary pulmonary arterial hypertension had developed.

                                                         General comparison
Symptom Me with ossification IPF patient without ossification
Scarring Little to no honeycombing Honeycombing
Cough None Cough
Crackles in lungs Little to no crackles Crackles
Scarring location Extensively in the lower lobes of the lungs Throughout lungs
Eligibility for clinical trials Unlikely Likely
Treatment Same Same
Prognosis Same Same
ILD classification Does not fit into usual interstitial pneumonia (UIP) or nonspecific UIP (NUIP). In unclassifiable category. It can be classified into an ILD category.

 

I was confident that I have two rare and unique diseases: IPF and dendriform ossification. Now, I was unclassifiable and called Abby Normal.

It bothered me that the cause of my PF was unknown. Previously, the causes of my blood clots and pulmonary embolisms were undetermined. I needed some closure. Finally, my biopsy provided some clues. It helped me to understand my IPF. If you had a biopsy, reread your findings and see if you can find an indicator.

***

Note: Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Pulmonary Fibrosis News or its parent company, Bionews, and are intended to spark discussion about issues pertaining to pulmonary fibrosis.

Leave a comment

Fill in the required fields to post. Your email address will not be published.